Literature DB >> 18493892

CO2 pneumoperitoneum increases survival in mice with polymicrobial peritonitis.

M Metzelder1, J F Kuebler, A Shimotakahara, D-H Chang, G Vieten, B Ure.   

Abstract

PURPOSE: Laparoscopic techniques are commonly used in patients with bacterial peritonitis. CO2 is known to suppress local and systemic inflammatory responses. Nonetheless, an active immune system is needed to contain bacterial contamination of the abdominal cavity. Therefore, we investigated the early and late effects of CO2 pneumoperitoneum on the ability of mice to overcome polymicrobial peritonitis.
MATERIAL AND METHODS: Male C57/B6 mice were subjected to pneumoperitoneum with CO2 or helium, or underwent a midline laparotomy. In a first set, changes of arterial blood gases were monitored. In further experiments, polymicrobial peritonitis was induced after 1 h of pneumoperitoneum/laparotomy by cecal ligation and puncture. In a second set of experiments polymicrobial peritonitis was induced 4 h prior to exposure to pneumoperitoneum/laparotomy. After the interventions, survival rates (early survival: 6 to 48 h; late survival > 48 h) were monitored for 7 days.
RESULTS: There was no significant effect of pneumoperitoneum or laparotomy on arterial blood gas parameters. CO2 pneumoperitoneum significantly reduced the early (6 to 48 h) mortality of subsequent peritonitis after CO2 pneumoperitoneum compared to laparotomy (2/20 vs. 9/25; p < 0.05). The protective effect did not reach significance after 7 days (late mortality). The application of a helium peritoneum did not show any beneficial effect. Application of a CO2 pneumoperitoneum during polymicrobial peritonitis significantly reduced overall mortality (p < 0.05) compared to laparotomy.
CONCLUSIONS: The modulation of immune responses by CO2, but not helium pneumoperitoneum, has a significant positive impact on survival during abdominal sepsis in a mouse model. Thus, application of a CO2 pneumoperitoneum may be beneficial in conditions with bacterial contamination of the abdominal cavity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18493892     DOI: 10.1055/s-2008-1038365

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  6 in total

1.  Conversion of laparoscopic surgery for perforated peptic ulcer: a single-center study.

Authors:  Markus Zimmermann; Martin Hoffmann; Tilman Laubert; Carlo Jung; Hans-Peter Bruch; Erik Schloericke
Journal:  Surg Today       Date:  2015-01-10       Impact factor: 2.549

2.  Moderate hypercapnia exerts beneficial effects on splanchnic energy metabolism during endotoxemia.

Authors:  Alex Gnaegi; François Feihl; Olivier Boulat; Bernard Waeber; Lucas Liaudet
Journal:  Intensive Care Med       Date:  2009-04-17       Impact factor: 17.440

Review 3.  Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS?

Authors:  Gerard Curley; Mairead Hayes; John G Laffey
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

4.  CO2 pneumoperitoneum preserves β-arrestin 2 content and reduces high mobility group box-1 (HMGB-1) expression in an animal model of peritonitis.

Authors:  Angela Simona Montalto; Alessandra Bitto; Letteria Minutoli; Pietro Impellizzeri; Gaetano Costa; Natasha Irrera; Gabriele Pizzino; Francesco Squadrito; Domenica Altavilla; Carmelo Romeo
Journal:  Oxid Med Cell Longev       Date:  2015-02-24       Impact factor: 6.543

5.  Emergency laparoscopic ileo-colic resection and primary intracorporeal anastomosis for Crohn's acute ileitis with free perforation and faecal peritonitis: first ever reported laparoscopic treatment.

Authors:  A Birindelli; G Tugnoli; D Beghelli; A Siciliani; A Biscardi; C Bertarelli; S Selleri; R Lombardi; S Di Saverio
Journal:  Springerplus       Date:  2016-01-06

6.  Does Helium Pneumoperitoneum Reduce the Hyperinflammatory Response in Septic Animals during Laparoscopy?

Authors:  Paulo Roberto Rodrigues Bicalho; Fernanda Magna Ribeiro; Pedro Henrique Ferreira Marçal; Daniel Gomes de Alvarenga; Fernando de Sá Silva
Journal:  Surg Res Pract       Date:  2020-03-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.